Literature DB >> 20206677

Pharmacokinetic comparisons of hydroxysafflower yellow A in normal and blood stasis syndrome rats.

Yun Tian1, Zhi-Fu Yang, Yan Li, Yi Qiao, Jing Yang, Yan-Yan Jia, Ai-Dong Wen.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Safflower is a popular Traditional Chinese Medicine (TCM) to invigorate the blood and dispel 'blood stasis', which arises from poor blood circulation. The differences of pharmacokinetic properties between normal and blood stasis syndrome rats were seldom reported. AIM OF THE STUDY: The present study was conducted to evaluate the pharmacokinetics of hydroxysafflower yellow A (HSYA) following oral administration of hydroxysafflower yellow A and safflower extract with approximately the same dose of HSYA 100mg/kg in both normal and acute blood stasis rats.
MATERIALS AND METHODS: The animals were orally administered with HYSA monomer and safflower extract. The blood samples were collected according to the time schedule. The concentrations of HSYA in rat plasma were determined by HPLC. Various pharmacokinetic parameters were estimated from the plasma concentration versus time data using non-compartmental methods.
RESULTS: It was found that AUC(0-t), C(max), Vd and CL of HSYA in both HSYA monomer and safflower extract in acute blood stasis rats were with significant difference (P<0.05) comparing with that in normal rats.
CONCLUSIONS: The results indicated that HSYA was with high uptake and eliminated slowly in the animals with blood stasis syndrome, suggesting that the rate and extent of drug metabolism was altered in acute blood stasis animals. (c) 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20206677     DOI: 10.1016/j.jep.2010.02.023

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  22 in total

1.  Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Authors:  Shujun Jiang; Zhen Shi; Changyong Li; Chunlei Ma; Xianyong Bai; Chaoyun Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

2.  Pharmacokinetic comparison of ferulic acid in normal and blood deficiency rats after oral administration of Angelica sinensis, Ligusticum chuanxiong and their combination.

Authors:  Weixia Li; Jianming Guo; Yuping Tang; Huan Wang; Meiyan Huang; Dawei Qian; Jin-Ao Duan
Journal:  Int J Mol Sci       Date:  2012-03-16       Impact factor: 5.923

3.  Pretreatment with β-Boswellic Acid Improves Blood Stasis Induced Endothelial Dysfunction: Role of eNOS Activation.

Authors:  Mingming Wang; Minchun Chen; Yi Ding; Zhihui Zhu; Yikai Zhang; Peifeng Wei; Jingwen Wang; Yi Qiao; Liang Li; Yuwen Li; Aidong Wen
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

4.  Protective effects of traditional Chinese medicine formula NaoShuanTong capsule on haemorheology and cerebral energy metabolism disorders in rats with blood stasis.

Authors:  Hong Liu; Yao-Yao Peng; Feng-Yin Liang; Si Chen; Pei-Bo Li; Wei Peng; Zhong-Zheng Liu; Cheng-Shi Xie; Chao-Feng Long; Wei-Wei Su
Journal:  Biotechnol Biotechnol Equip       Date:  2014-01-02       Impact factor: 1.632

5.  Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats.

Authors:  Zipeng Gong; Ying Chen; Ruijie Zhang; Yinghan Wang; Yan Guo; Qing Yang; Haixian Zhang; Yu Dong; Xiaogang Weng; Shuangrong Gao; Xiaoxin Zhu
Journal:  Int J Mol Sci       Date:  2014-01-02       Impact factor: 5.923

6.  Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial.

Authors:  Yue-li Sun; Ting Hou; Shu-fen Liu; Zhong-liang Zhang; Ning Zhang; Min Yao; Long Yang; Qi Shi; Xue-jun Cui; Yong-jun Wang
Journal:  Trials       Date:  2015-02-26       Impact factor: 2.279

7.  Core bioactive components promoting blood circulation in the traditional Chinese medicine compound xueshuantong capsule (CXC) based on the relevance analysis between chemical HPLC fingerprint and in vivo biological effects.

Authors:  Hong Liu; Jie-ping Liang; Pei-bo Li; Wei Peng; Yao-yao Peng; Gao-min Zhang; Cheng-shi Xie; Chao-feng Long; Wei-wei Su
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

8.  Enhanced absorption of hydroxysafflor yellow A using a self-double-emulsifying drug delivery system: in vitro and in vivo studies.

Authors:  Liang-Zhong Lv; Chen-Qi Tong; Qing Lv; Xin-Jiang Tang; Li-Ming Li; Qing-Xia Fang; Jia Yu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2012-07-30

9.  Mechanism of enhanced oral absorption of hydrophilic drug incorporated in hydrophobic nanoparticles.

Authors:  Liang-Zhong Lv; Chen-Qi Tong; Jia Yu; Min Han; Jian-Qing Gao
Journal:  Int J Nanomedicine       Date:  2013-07-29

10.  Pharmacokinetics and tissue distribution study of tanshinone IIA after oral administration of Bushen Huoxue Qubi granules to rats with blood stasis syndrome.

Authors:  Yuanqing Wang; Jianye Yan; Shunxiang Li; Xiong Cai; Wei Wang; Kun Luo; Dan Huang; Jiesheng Gao
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.